Paper563229
Mitogenic activity of adjuvant-active N-acetylmuramyl-L-alanyl-D-isoglutamine and its analogues.
Takada H and 4 others. Biken J, 1977. Cited by 26 papers, by iCite.
Cite this record
ConductScience Library. Mitogenic activity of adjuvant-active N-acetylmuramyl-L-alanyl-D-isoglutamine and its analogues. Papers, record 563229. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/563229
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Mitogenic activity of adjuvant-active N-acetylmuramyl-L-alanyl-D-isoglutamine and its analogues.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glycopeptides | Major topic |
| Lymphocytes | Major topic |
| Mitogens | Major topic |
| Animals | |
| Cells, Cultured | |
| Guinea Pigs | |
| Lymphocyte Activation | |
| Mice | |
| Mice, Inbred ICR | |
| Spleen |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7054120 | N-acetyl muramyl dipeptide stimulation of bone resorption in tissue culture. | Infect Immun | 1982 | https://conductscience.org/library/papers/7054120 | PubMed |
| 7054119 | Correlation between in vivo anti-Pseudomonas and anti-Candida activities and clearance of carbon by the reticuloendothelial system for various muramyl dipeptide analogs, using normal and immunosuppressed mice. | Infect Immun | 1982 | https://conductscience.org/library/papers/7054119 | PubMed |
| 7019079 | Stimulation of nonspecific resistance to infection induced by 6-O-acyl muramyl dipeptide analogs in mice. | Infect Immun | 1981 | https://conductscience.org/library/papers/7019079 | PubMed |
| 7012020 | Chemical and biological properties of a peptidoglycan isolated from Treponema pallidum kazan. | Infect Immun | 1981 | https://conductscience.org/library/papers/7012020 | PubMed |
| 478648 | Macrophage activation by bacterial cell walls and related synthetic compounds. | Infect Immun | 1979 | https://conductscience.org/library/papers/478648 | PubMed |
| 457276 | Inhibition of macrophage migration by muramyl peptides. | Infect Immun | 1979 | https://conductscience.org/library/papers/457276 | PubMed |
| 457275 | Stimulation of the reticuloendothelial system of mice by muramyl dipeptide. | Infect Immun | 1979 | https://conductscience.org/library/papers/457275 | PubMed |
| 317594 | Relationships between adjuvant, immunosuppressive, and mitogenic activities of staphylococcal peptidoglycan. | Infect Immun | 1979 | https://conductscience.org/library/papers/317594 | PubMed |
| 314932 | Mitogenic effects of bacterial cell walls, their fragments, and related synthetic compounds on thymocytes and splenocytes of guinea pigs. | Infect Immun | 1979 | https://conductscience.org/library/papers/314932 | PubMed |
| 313370 | Mitogenic activity of staphylococcal peptidoglycan. | Infect Immun | 1979 | https://conductscience.org/library/papers/313370 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/563229
GET https://conductscience.org/api/papers/v1/563229/authors